Bernard Mulder has more than two decades of experience in the life sciences industry. He worked for Organon for 12 years, of which he spent 10 years abroad in Asia, Europe and the USA. He held several medical, marketing, sales and managerial positions in the different countries. After returning to the Netherlands, he worked as Global VP Marketing, Sales and Business Development for Avantium Pharma. In 2011, Bernard co-founded Eagle Rock Life Sciences to support life sciences enterprises from early start-ups to mature companies (hands-on) and also invested in start-ups. Most recently, he worked for Boehringer Ingelheim for the medical department. Bernard earned his medical degree at Leiden University and his MBA from New York Institute of Technology.
Olaf Geurts joined RegMed XB as Finance Manager in May 2021. After receiving his master’s degree in Economics and Business Administration from Maastricht University (1993), Olaf has worked in a number of finance roles in automotive and related industries. As a director of an automotive holding company he was responsible for Finance, HR and IT for the last 8 years prior to starting at RegMed XB.
Lena Wijnen is a Project Manager at RegMedXB. She obtained a research master in Epidemiology at the University of Utrecht and a master in Healthcare Policy, Innovation and Management at the university of Maastricht. She gained experience with different academic research topics during various internships in the Netherlands and abroad.
Omar Paulino da Silva Filho is the Project Manager at RegMed XB. He is a Pharmacist with research interests in drug delivery and regenerative medicine. In 2014, he started a PhD program at the biochemistry department at Radboud University (Nijmegen, The Netherlands), under the guidance of prof. Dr Roland Brock. He investigated the fundamental applications of cell-penetrating peptides as a drug delivery system. He focused on the development of protective peptide that can be used to support islet transplantation and contributed to the development of different strategies for corneal regeneration. In 2019, he started working as a research fellow for the islet group and the directing cell fate group at the MERLN Institute for Technology-Inspired Regenerative Medicine (Maastricht, The Netherlands). From November 2021, he joined RegMed XB to support the progress of regenerative medicine alternatives for patients.
Mr. Sophie-Charlotte Snoeijs is the Operations Manager for RegMed XB. She studied European and international law at the Radboud University and received her master of law degree at the Maastricht University with the main focus on business law. After years of experience in various legal fields in the Netherlands and Belgium she wanted to use her analytical and organize skills within a meaningful socially engaged job. Therefore, she is proud to be a member of the RegMed XB team and contribute to improving the life of patients.
Claudia, as a senior Management Assistant, has gained a lot of experience in business over the last 20 years. Her early career roots lie in health care where she spent the first 20 years of her career providing care 'at the bedside' as a nurse and worked for several years in care for the deafblind. Her ambitions made her switch to business in combination with a retraining to become a Management Assistant. A good choice she never regretted. At RegMed XB, Claudia is responsible for the complete back office and with great joy she supports the management team at the Maastricht office. The developments within RegMed XB are promising and Claudia is happy to be part of this.